GS-US-342-0102 'A PHASE 2, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF SOFOSBUVIR + GS-5816 FOR 12 WEEKS IN TREATMENT-NAIVE SUBJECTS WITH CHRONIC HCV INFECTION'

Biotechnology Computer Science Energy Engineering Environmental Sciences Information Science Life Sciences Mathematics Medical Sciences

Military Sciences Natural Sciences Physical Sciences Plant Sciences Science Space Sciences Technology Transportation